Author ' s response to reviews Title : Randomized phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer : a comparison of different schedules and treatments

A. Durando,D. Merlo
Abstract:Lucia Del Mastro (lucia.delmastro@istge.it) Alessandra Fabi (fabi@ifo.it) Mauro Mansutti (mansutti.mauro@aoud.sanita.fvg.it) Michele De Laurentiis (delauren@unina.it) Antonio Durando (antonio.durando@libero.it) Domenico Franco Merlo (franco.merlo@istge.it) Paolo Bruzzi (paolo.bruzzi@istge.it) Ignazia La Torre (cinzialt@yahoo.com) Matteo Ceccarelli (ceccarelli_matteo@lilly.com) Gbenga Kazeem (benkaz.oxbridge@gmail.com) Paolo Marchi (marchi_paolo@lilly.com) Davide Boy (boy_davide@lilly.com) Marco Venturini (ccc@ccc.dd) Sabino De Placido (sdponco@unina.it) Francesco Cognetti (cognetti@ifo.com)
What problem does this paper attempt to address?